NASDAQ:CRSP

Crispr Therapeutics Stock Predictions

etoro logo Buy CRSP
*Your capital is at risk
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CRSP Prediction Chart

CRSP Predictions History

Latest community submissions for CRSP.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 18, 2025 $49.06 -1.33% $52.22 X 93.95% 0
Feb 18, 2025 $58.04 +33.46% $52.22 V 88.85% 1
Feb 12, 2025 $40.41 +1.99% $43.30 V 93.33% 1
Feb 12, 2025 $40.11 +1.25% $43.30 V 92.64% 1
Feb 12, 2025 Bullish $43.30 V 1
Jan 15, 2025 $39.23 +2.26% $39.04 V 99.53% 5
Jan 15, 2025 $38.90 +1.41% $39.04 V 99.64% 5
Jan 15, 2025 Bearish $39.04 X 0
Nov 11, 2024 $50.79 -1.61% $54.86 X 92.58% 0
Nov 11, 2024 $51.10 -1.01% $54.86 X 93.15% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CRSP with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CRISPR THERAPEUTICS AG
CRISPR Therapeutics
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglo...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE